Aktiesnakken — September 2013
-
jep Solsen. Den gamle top er 220. vi får en ny YTD high igen i løbet af 2013
-
250 er mit bud på lukkekurs 31/12 2013
-
tja Solsen, Deutsche giver da gas nu
-
Så i er ikke uenige med mig når jeg siger 4 cifret kurs inden 2018 ?
-
jo jeg er
-
jeg tror på 250 i 2014
-
der er ikke noget der kan købe genmab uden at aktionærerne siger ja.
-
De får svært med at gå overbevist både GSK og Janssen om at det skulle være strategisk fordelagtigt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind